Roberta Littleford

MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1

Michael Flower, Vilija Lomeikaite, Marc Ciosi et al. · Brain · 2019 · 169 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): study protocol for a randomized controlled trial

Frank Sullivan, Eoghan C. W. Farmer, Frances S Mair et al. · BMC Cancer · 2017 · 159 citations · Full text

Medicine, Immunology, Oncology +17

Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imaging

Frank Sullivan, Frances S Mair, William E. Anderson et al. · European Respiratory Journal · 2020 · 137 citations · Full text

Medicine, Oncology, Radiology +17

Left Ventricular Noncompaction

Jonathan Weir‐McCall, Phey Ming Yeap, Carla Papagiorcopulo et al. · Journal of the American College of Cardiology · 2016 · 135 citations · Full text

Medicine, Cardiology, Genetics +13

Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial

Kees Okkersen, Cecilia Jimenez‐Moreno, Stephan Wenninger et al. · The Lancet Neurology · 2018 · 121 citations · Full text

Medicine, Rehabilitation Medicine, Physical Activity +11